Clinical Trial Update: Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing TroVax alone to TroVax plus GM-CSF in patients with prostate cancer, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• TroVax

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED